|
|
|
This is the preliminary program for the 2009 Joint Statistical
Meetings in Washington, DC.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2009 Program page |
= Applied Session,
= Theme Session,
= Presenter| 481 | Wed, 8/5/09, 12:30 PM - 1:50 PM | CC-Ballroom South Prefunction |
| Biopharmaceutical Section Roundtables with Lunch (fee event) - Roundtables - with Lunch | ||
|
Biopharmaceutical Section |
||
| Organizer(s): Dionne Price, FDA | ||
| WL10: |
Issues and Challenges in Modeling Bioassay Data —  Jason Liao, Merck Research Laboratories
|
|
| WL11: |
Advanced Oncology Trial Designs — Mingxiu Hu, Millennium Pharmaceuticals/The Takeda Oncology Company
|
|
| WL12: |
Adaptive Clinical Trials: Interim Data Analysis Challenges — Darcy Hille, Merck & Co., Inc.; Paulette Ceesay, Merck & Co., Inc.
|
|
| WL13: |
The Role of the Unblinded Statistician and Their Relationship with the DSMB — Valerie Durkalski, Medical University of South Carolina
|
|
| WL14: |
Retrospective Studies of Biomarkers: How Can They Improve Our Understanding of Drug Use? — Estelle Russek-Cohen, FDA
|
|
| WL15: |
Clinical Trials in Practice: Designs, Monitoring, and Data Analysis — Daohai Yu, H. Lee Moffitt Cancer Center & Research Institute
|
|
|
JSM 2009
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |